3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione
3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione Basic information
- Product Name:
- 3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione
- Synonyms:
-
- 3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione
- 3-(5-fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione
- PF-06840003
- 2,5-Pyrrolidinedione, 3-(5-fluoro-1H-indol-3-yl)-
- 3-(5-Fluoro-1H-indol-3-yl)-2,5-pyrrolidinedione
- PF-06840003 (racemate)
- EOS200271
- PF 06840003;PF-06840003
- CAS:
- 198474-05-4
- MF:
- C12H9FN2O2
- MW:
- 232.21
- Product Categories:
-
- API
- Mol File:
- 198474-05-4.mol
3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione Chemical Properties
- storage temp.
- Inert atmosphere,Room Temperature
- solubility
- Soluble in DMSO (up to at least 25 mg/ml)
- form
- solid
- color
- White
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione Usage And Synthesis
Description
PF-06840003 (198474-05-4) is a potent (IC50?= 150 and 410 nM via two methods) and selective inhibitor of Indoleamine-2,3-dioxygenase (IDO1).1?In mice with syngeneic tumor grafts, it reduced intratumoral kynurenine levels by over 80%, inhibited tumor growth as monotherapy, and increased the efficacy of anti-PD-L1 therapy.2?PF-06840003 treatment combined with GM-CSF-secreting allogenic pancreatic tumor cell vaccine (GVAX) resulted in increased antitumor efficacy in a murine model of pancreatic ductal adenocarcinoma.3
Uses
PF-06840003 is a potential clinical candidate as a novel and selective Indoleamine 2,3-dioxygenase inhibitor. Highly selective and orally bioavailable IDO-1 inhibitor.
References
1) Crosignani?et al.?(2017),?Discovery of a Novel and Selective Indoleamine-2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EROS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate;?J. Med. Chem.?60?9617 2) Gomes?et al.?(2018),?Characterization of the Selective Indoleamine-2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy;?Mol. Cancer Ther.?9?2530 3) Blair?et al.?(2019),?IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma;?J. Clin. Invest.?129?1742
3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dioneSupplier
- Tel
- sales@boylechem.com
- Tel
- 021-20908456
- sales@BioChemBest.com
- Tel
- 021-54308259
- info@hanhongsci.com
- Tel
- 16314854226
- info@bocsci.com
- Tel
- 0411-62910999 13889544652
- sales@meilune.com
3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione(198474-05-4)Related Product Information
- PF-04979064
- PF-3758309
- PF-05212384
- PF-06281355
- PF-562271
- Ketohexokinase inhibitor 1
- PF-6274484
- PF-9366
- 4-[(Diethylamino)methyl]-N-[2-(2-methoxyphenyl)ethyl]-N-(3R)-3-pyrrolidinylbenzamide
- PF06869206
- 8-Nitrotryptanthrin
- Β-LAPACHONE
- IDO-IN-1
- IDO-IN-7
- indoleaMine-2,3-dioxygenase inhibitor INCB024360
- NLG919
- IDO-IN-4
- 1-METHYL-D-TRYPTOPHAN